Regulation of Alternative Splicing in B-Cell ALL By DYRK1A

被引：0

作者：

Jin, Qi ^{[1
]}

Harris, Ethan ^{[1
]}

Myers, Jacquelyn A. ^{[2
]}

Cotton, Anitria ^{[3
]}

Wen, Jeremy ^{[3
]}

Melo-Cardenas, Johanna ^{[1
]}

Yoshimi, Akihide ^{[4
]}

Abdel-Wahab, Omar ^{[5
]}

Obeng, Esther A. ^{[2
]}

Crispino, John D. ^{[3
]}

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN USA

[2] St Jude Childrens Res Hosp, Oncol, Memphis, TN USA

[3] St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN USA

[4] Natl Canc Ctr, Tokyo, Japan

[5] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174923

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation
Kaltheuner, Ines H.
Anand, Kanchan
Moecking, Jonas
Duester, Robert
Wang, Jinhua
Gray, Nathanael S.
Geyer, Matthias
NATURE COMMUNICATIONS, 2021, 12 (01)
[32] CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition
Abdolazimi, Yassan
Zhao, Zhengshan
Lee, Sooyeon
Xu, Haixia
Allegretti, Paul
Horton, Timothy M.
Yeh, Benjamin
Moeller, Hannah P.
Nichols, Robert J.
McCutcheon, David
Shalizi, Aryaman
Smith, Mark
Armstrong, Neali A.
Annes, Justin P.
ENDOCRINOLOGY, 2018, 159 (09) : 3143 - 3157
[33] B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation
Liat Stoler-Barak
Ethan Harris
Ayelet Peres
Hadas Hezroni
Mirela Kuka
Pietro Di Lucia
Amalie Grenov
Neta Gurwicz
Meital Kupervaser
Bon Ham Yip
Matteo Iannacone
Gur Yaari
John D. Crispino
Ziv Shulman
Nature Communications, 14
[34] DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
Yousefelahiyeh, Mina
Xu, Jingyi
Alvarado, Estibaliz
Yu, Yang
Salven, David
Nissen, Robert M.
PLOS ONE, 2018, 13 (11):
[35] B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation
Stoler-Barak, Liat
Harris, Ethan
Peres, Ayelet
Hezroni, Hadas
Kuka, Mirela
Di Lucia, Pietro
Grenov, Amalie
Gurwicz, Neta
Kupervaser, Meital
Yip, Bon Ham
Iannacone, Matteo
Yaari, Gur
Crispino, John D.
Shulman, Ziv
NATURE COMMUNICATIONS, 2023, 14 (01)
[36] Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
Walmsley, David Lee
Murray, James B.
Dokurno, Pawel
Massey, Andrew J.
Benwell, Karen
Fiumana, Andrea
Foloppe, Nicolas
Ray, Stuart
Smith, Julia
Surgenor, Allan E.
Edmonds, Thomas
Demarles, Didier
Burbridge, Mike
Cruzalegui, Francisco
Kotschy, Andras
Hubbard, Roderick E.
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 8971 - 8991
[37] A natural DYRK1A inhibitor as a potential stimulator for β-cell proliferation in diabetes
Zheng, Mengzhu
Zhang, Qingzhe
Zhang, Chengliang
Wu, Canrong
Yang, Kaiyin
Song, Zhuorui
Wang, Qiqi
Li, Chen
Zhou, Yirong
Chen, Jiachun
Li, Hua
Chen, Lixia
CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (07):
[38] DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
Barzowska, Agata
Pucelik, Barbara
Pustelny, Katarzyna
Matsuda, Alex
Martyniak, Alicja
Stepniewski, Jacek
Maksymiuk, Anna
Dawidowski, Maciej
Rothweiler, Ulli
Dulak, Jozef
Dubin, Grzegorz
Czarna, Anna
CELLS, 2021, 10 (09)
[39] Regulation of RCAN1 Protein Activity by Dyrk1A Protein-mediated Phosphorylation
Jung, Min-Su
Park, Jung-Hwa
Ryu, Young Shin
Choi, Sun-Hee
Yoon, Song-Hee
Kwen, Mi-Yang
Oh, Ji Youn
Song, Woo-Joo
Chung, Sul-Hee
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (46) : 40401 - 40412
[40] Imbalance in Alternative Splicing of MCL-1 Inhibits Apoptosis in Diffuse Large B-Cell Lymphoma
Rekers, Nicolle H.
Moesbergen, Laura M.
Hijmering, Nathalie J.
Vos, Wim
Oudejans, Joost
Ossenkoppele, Gert J.
Meijer, Chris J. L. M.
Cillessen, Saskia A. G. M.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →